Minerva Neuroscie (NERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 6,278 | 6,682 | 7,172 | 6,079 | 4,520 |
| Operating Income | -6,278 | -6,682 | -7,172 | -6,079 | -4,520 |
| Other Income | -1,956 | -1,887 | -1,851 | -1,741 | -1,672 |
| Pre-tax Income | -8,234 | -8,569 | -9,023 | -7,820 | -6,192 |
| Net Income Continuous | -8,234 | -8,569 | -9,023 | -7,820 | -6,192 |
| Net Income | $-8,234 | $-8,569 | $-9,023 | $-7,820 | $-6,192 |
| EPS Basic Total Ops | -1.09 | -1.13 | -1.15 | -1.03 | -1.12 |
| EPS Basic Continuous Ops | -1.09 | -1.13 | -1.15 | -1.03 | -1.12 |
| EPS Diluted Total Ops | -1.09 | -1.13 | -1.15 | -1.03 | -1.12 |
| EPS Diluted Continuous Ops | -1.09 | -1.13 | -1.15 | -1.03 | -1.12 |
| EPS Diluted Before Non-Recurring Items | -1.09 | -1.13 | -1.19 | N/A | N/A |
| EBITDA(a) | $-6,270 | $-6,674 | $-7,164 | $-6,071 | $-4,512 |